Publications

5674 Results

Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach

Authors
M Redman;C Tangen;P Goodman;MS Lucia;CA Coltman;IM Thompson
Journal / Conference
Cancer Prevention Research 1(3):174-181
Year
2008
Research Committee(s)
Cancer Control
PMID
PMID: 19138953
PMC
PMC2844801
Study Number(s)
SWOG-9217

Phase II Southwest Oncology Group study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive, stage IV breast cancer

Authors
J Kash;WE Barlow;KS Albain;JR Gralow;D Lew;LE Flaherty;ME Royce;GN Hortobagyi;RB Livingston
Journal / Conference
Journal of Clinical Oncology 26(15S):49s, #1033
Year
2008
Research Committee(s)
Breast
Study Number(s)
S0215

Weekly paclitaxel in the adjuvant treatment of breast cancer [PMC2743943; PMID18420499]

Authors
JA Sparano;M Wang;S Martino;V Jones;EA Perez;TJ Saphner;AC Wolff;GW Sledge;WC Wood;NE Davidson
Journal / Conference
New England Journal of Medicine 358(16):1663-1771
Year
2008
Research Committee(s)
Breast
Study Number(s)
E1199

NSABP B30: Definitive analysis of patient outcome from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer.

Authors
SM Swain;HJ Jeong;CE Geyer;JP Costantino;ER Pajon;L Fehrenbacher;JN Atkins;JA Polikoff;VG Vogel;JK Erban;RB Livingston;E Perez;EP Mamounas;PA Ganz;SR Land;N Wolmark
Journal / Conference
San Antonio Breast Cancer Symposium, abstract #75
Year
2008
Research Committee(s)
Breast

Arsenic trioxide consolidation improves event-free and overall survival among patients with newly diagnosed acute promyelocytic leukemia: North American Intergroup protocol C9710

Authors
BL Powell;B Moser;W Stock;RE Gallagher;CL Willman;RM Stone;JM Rowe;SE Coutre;JH Feusner;J Gregory;S Couban;FR Appelbaum;MS Tallman;RA Larson
Journal / Conference
Annals of Hematology 87(Suppl. 1):S77-S78
Year
2008
Research Committee(s)
Leukemia
Study Number(s)
C9710

Progress in small cell lung cancer: the lowest common denominator [PMID18779609]

Authors
DR Gandara;PN Lara, Jr.;RB Natale;C Belani
Journal / Conference
Journal of Clinical Oncology 26(26):4236-4238
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0124

Predictors of survival in advanced renal cell carcinoma (RCC): long-term results from Southwest Oncology Group trial S8949

Authors
S Conlon;CM Tangen;RC Flanigan;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15S):260s, #5042
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8949

An update of pharmacogenetic analysis of adjuvant rectal cancer patients treated with 5-Fluorouracil and pelvic radiation in a phase III intergroup trial (INT-0144, SWOG 9304)

Authors
W Zhang;C Rankin;KD Danenberg;JK Benedetti;PV Danenberg;CM Ulrich;RS Holmes;KW Makar;CD Blanke;SR Smalley;HJ Lenz
Journal / Conference
Journal of Clinical Oncology 26(15S):206s, #4115
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)

Use of prostate-specific antigen progression (PSA-P) to predict overall survival (OS) in patients (pts) with metastatic prostate cancer (PC): data from S9346 and S9916

Authors
MHA Hussain;B Goldman;CM Tangen;C Higano;DP Petrylak;ED Crawford
Journal / Conference
Journal of Clinical Oncology 26(15S):253s, #5015
Year
2008
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer pataients (SWOG 9304)

Authors
RS Holmes;C Rankin;KW Makar;JK Benedetti;SR Smalley;CD Blanke;HJ Lenz;CM Ulrich
Journal / Conference
Proceedings of the American Association for Cancer Research, abst. 4797
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9304 (INT-0144)